Search the Newsreel

Die Medtronic-Aktie steigt nach Zulassungsschub und solider Prognose

Kornitzer Capital Management Inc. KS Reduces Position in Medtronic PLC $MDT

Kornitzer Capital Management Inc. KS reduced its stake in Medtronic PLC (NYSE:MDT) by 15.6% in the second quarter, now owning 103,155 shares valued at $8.07 million. Other institutional investors also adjusted their positions, and analysts have issued various ratings and price targets for MDT. …

Lecap Asset Management Ltd. Invests $1.13 Million in Medtronic PLC $MDT

Lecap Asset Management Ltd. recently purchased a new position in Medtronic PLC (NYSE:MDT), acquiring 14,453 shares valued at approximately $1.13 million during the second quarter. Other institutional investors like Brighton Jones LLC and Main Street Financial Solutions LLC also increased their stakes in Medtronic, …

Zhang Financial LLC Buys 12,259 Shares of Medtronic PLC $MDT

Zhang Financial LLC increased its stake in Medtronic PLC (NYSE:MDT) by 27.4% in the second quarter, acquiring an additional 12,259 shares and bringing its total holdings to 56,984 shares valued at $4,458,000. This move is part of broader institutional investment trends, with several other …

Cooke & Bieler LP Cuts Stake in Medtronic PLC $MDT

Cooke & Bieler LP reduced its stake in Medtronic PLC by 1.6% in the second quarter, selling 12,822 shares but still retaining 799,208 shares valued at $62.5 million. Institutional investors hold a significant 82.06% of Medtronic's stock. Despite some lowered price targets from analysts, …

Ascentis Independent Advisors Sells 11,711 Shares of Medtronic PLC $MDT

Ascentis Independent Advisors significantly reduced its stake in Medtronic PLC by 93.6%, selling 11,711 shares and retaining 803 shares valued at $63,000. Medtronic, a global medical technology company, recently reported strong quarterly revenues of $9.81 billion and adjusted earnings of $1.55 per share, surpassing …

Medtronic PLC $MDT Shares Sold by Associated Banc Corp

Associated Banc Corp decreased its stake in Medtronic PLC (NYSE:MDT) by 33.1% in the second quarter, selling 58,703 shares and leaving it with 118,886 shares valued at $9.3 million. Other institutional investors also adjusted their holdings, with some increasing and some decreasing their positions …

Assetmark Inc. Purchases 170,741 Shares of Medtronic PLC $MDT

Assetmark Inc. significantly increased its stake in Medtronic PLC, purchasing an additional 170,741 shares, bringing its total holdings to 815,888 shares valued at $63.8 million. Other major institutional investors like Vanguard Group, State Street Corp, and JPMorgan Chase & Co. also boosted their positions …

Medtronic PLC $MDT Shares Purchased by Aberdeen Group plc

Aberdeen Group plc increased its stake in Medtronic PLC (NYSE:MDT) by 13.3% in the second quarter, now owning 2,990,059 shares valued at $233,912,000. Other institutional investors also adjusted their positions in Medtronic, while an EVP sold over 4,000 shares. Analysts have a "Moderate Buy" …

How Record Hernia Mesh Verdict and New Cardiac System Approval Will Impact Medtronic (MDT) Investors

In August 2026, a federal jury ordered Medtronic to pay US$88,000,000 in compensatory damages over injuries linked to Covidien hernia mesh, while Medtronic Canada received Health Canada approval for its Affera Integrated Mapping and Ablation System for treating atrial fibrillation and atrial flutter. The …

Medtronic (MDT) Wins Health Canada Nod For Affera Heart Rhythm System

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Medtronic (NYSE:MDT) has received Health Canada approval for its Affera Integrated Mapping System and Sphere-9 Catheter for the treatment of atrial fibrillation and …

Medtronic PLC $MDT Shares Sold by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. reduced its stake in Medtronic PLC (NYSE:MDT) by 9.7% in the second quarter, selling 32,871 shares and retaining 304,895 shares valued at approximately $23.9 million. Other institutional investors also adjusted their holdings, with 82.06% of the stock now owned …

Oregon Public Employees Retirement Fund Boosts Stock Position in Medtronic PLC $MDT

The Oregon Public Employees Retirement Fund increased its stake in Medtronic PLC by 7.6% in the second quarter of 2026, adding 11,167 shares to now hold 157,862 shares valued at $12.35 million. Institutional investors collectively own 82.06% of Medtronic, and analysts have a consensus …

Medtronic PLC $MDT Shares Bought by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC significantly increased its stake in Medtronic PLC (NYSE:MDT) during the second quarter, purchasing an additional 11,094 shares, bringing their total to 20,060 shares valued at $1,645,000. Other institutional investors also adjusted their holdings, with the company's stock currently having …

AJJ Medtech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

MicroPort CardioFlow Medtech Sets Board Meeting to Approve Interim Results and Consider Dividend

28,448 Shares in Medtronic PLC $MDT Purchased by Sciencast Management LP

Sciencast Management LP recently acquired 28,448 shares of Medtronic PLC (NYSE:MDT), valued at approximately $2.23 million, making it a new institutional investor in the company. Medtronic continues to draw significant institutional interest, with 82.06% of its stock owned by such investors, despite some analysts …

Medtronic PLC $MDT Shares Acquired by Verity & Verity LLC

Verity & Verity LLC increased its stake in Medtronic PLC by 5.1% in the second quarter, acquiring 11,197 additional shares to hold a total of 229,707 shares valued at approximately $17.97 million. Institutional investors and hedge funds now own 82.06% of the company. Analysts …

Medtronic (NYSE:MDT) Combines Dividend Quality with a Sustainable Yield

Singapore's Medtecs HY profit jumps on higher revenue, lower taxes

Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny

Sanara MedTech (SMTI) recently turned profitable in Q2 2026, reporting net income of US$0.40m from continuing operations, a significant improvement from a loss in the prior year. Despite this positive shift and increased revenue, the stock's reaction was muted, with concerns remaining over thin …

Western Wealth Management LLC Has $1.77 Million Stock Position in Medtronic PLC $MDT

Western Wealth Management LLC significantly increased its stake in Medtronic PLC by 271.2% in the first quarter, now holding 20,382 shares valued at $1.77 million. Medtronic maintains a "Moderate Buy" consensus among analysts with an average price target of $98.83, following solid Q1 earnings …

Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar

Reassessing stock picks is one of the best habits an investor can build. Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions. The daily chart illustrates how well the stock has performed relative to its peers on …

Medtronic veteran departs for CEO role at heart valve startup

Bill Shields, a long-time Medtronic executive specializing in transcatheter mitral and tricuspid therapies, has been appointed CEO of Versa Vascular. Versa Vascular is a startup developing a minimally invasive transcatheter device called AdapTR to treat tricuspid valve regurgitation. Shields' appointment comes as Versa Vascular …

Fulton Bank N.A. Has $2.32 Million Stock Position in Medtronic PLC $MDT

Fulton Bank N.A. significantly increased its stake in Medtronic PLC by 65.1% in the second quarter, bringing its total holdings to 29,675 shares valued at $2.32 million. This move comes as Medtronic exceeded earnings and revenue expectations and raised its quarterly dividend. Analysts maintain …

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

Sanara MedTech Inc. announced its financial results for the second quarter and first six months of 2026, reporting increased net revenue and gross profit. The company's net revenue rose 9% to $28.1 million in Q2 2026 and 14% to $55.9 million for the first …

Does Medtronic (MDT) Still Trade At A Discount After Its CE Mark Win?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic stock has delivered a 20.8% gain over the past three years, yet current checks suggest it now sits close to its estimated …

Medtronic options activity shows heavy call buying ahead of September earnings

Ahead of its September 1 earnings, Medtronic (NYSE:MDT) has seen significant options activity, with call volume far outpacing puts. Nearly 19,000 contracts for a single $100 call option for September 2026 indicate strong bullish sentiment, suggesting traders anticipate a substantial upside surprise. This event-driven …

Hat die Heraufstufung von Medtronic (MDT) durch die UBS nach dem starken, vom Herzbereich getragenen Wachstum gerade das Anlage-Narrativ des Unternehmens verändert?

Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates

Sanara MedTech Inc. (SMTI) reported Q2 earnings of $0.05 per share, significantly beating the Zacks Consensus Estimate of $0.02, representing a 150% surprise. Despite missing revenue estimates at $28.14 million, the company's shares have gained 46.7% year-to-date. SMTI currently holds a Zacks Rank #3 …

¿La revisión al alza de Medtronic (MDT) por parte de UBS, tras un sólido crecimiento impulsado por el sector cardíaco, acaba de cambiar su perspectiva de inversión?

Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate